Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Conditions
Non Small Cell Lung Cancer · Lung Cancer · Breast Cancer · Esophageal Cancer · Small Cell Lung Cancer · Nasopharyngeal Cancer · Head and Neck Squamous Cell Carcinoma · Prostate Adenocarcinoma · Ovarian Cancer · Endometrial Cancer · Cervical Cancer · Triple Negative Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beverly Hills Cancer Center, Beverly Hills, California, United States
Contact: Principal Investigator (Afshin Gabayan, MD)City of Hope Cancer Center, Duarte, California, United States
Contact: Principal Investigator (Adam Rock, MD)Chao Family Comprehensive Cancer Care and Ambulatory Care, Irvine, California, United States
Contact: Study coordinator (Cathleen Park, MD)Contact: Principal Investigator (Cathleen Park, MD)Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
Contact: Principal Investigator (Cathleen Park, MD)University of California Irvine Medical Center, Orange, California, United States
Contact: Principal Investigator (Cathleen Park, MD)UCLA Santa Monica, Santa Monica, California, United States
Contact: Principal Investigator (Jonathan Goldman, MD)University of Colorado Cancer Center, Aurora, Colorado, United States
Contact: Principal Investigator (Tejas Patil, MD)Yale University, Yale Cancer Center, New Haven, Connecticut, United States
Contact: Principal Investigator (Scott Gettinger, MD)Georgetown University Medical Center, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Stephen Liu, MD)Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Gilberto Lopes, MD)Sara Cannon Research Institute Lake Nona, Orlando, Florida, United States
Contact: Principal Investigator (Cesar Perez Batista, MD)Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida, United States
Contact: Principal Investigator (Nicholas Iannotti, MD)Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Contact: Principal Investigator (Young Chae, MD)University of Iowa Hospital and Clinics, Iowa City, Iowa, United States
Contact: Principal Investigator (Sneha Phadke, MD)Norton Cancer Institute, Louisville, Kentucky, United States
Contact: Principal Investigator (John Hamm, MD)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Zofia Piotrowska, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Janne Pasi, MD, PhD)Memorial Sloan Kettering Cancer Center Head Neck Services, New York, New York, United States
Contact: Principal Investigator (Helena Yu, MD)PRISMA Health/ITOR, Greenville, South Carolina, United States
Contact: Principal Investigator (Jeffery Edenfield, MD)Sarah Cannon - Tennessee Oncology, Nashville, Tennessee, United States
Contact: Principal Investigator (Melissa Johnson, MD)Oncology Consultants, P.A., Houston, Texas, United States
Contact: Principal Investigator (Julio Peguero, MD)University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Xiuning Le, MD)Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira, MD)University of Washington Fred Hutchinson, Seattle, Washington, United States
Contact: Principal Investigator (Christina Baik, MD)Centre Léon Bérard, Lyon, France
Contact: Principal Investigator (Aurélie Swalduz, MD)Groupe Hospitalier Pitie-Salpetriere, Paris, France
Contact: Principal Investigator (Aurore Vozy, MD)Institut de Cancerologie de Ouest (ICO) - Saint-Herblain, Saint-Herblain, France
Contact: Principal Investigator (Sandrine Hiret, MD)Institut Gustave Roussy, Villejuif, France
Contact: Principal Investigator (Anas Gazzah, MD)Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Italy
Contact: Principal Investigator (Vanesa Gregorc, MD)IRCCS Istituto Clinico Humanitas, Cancer Center, Rozzano, Italy
Contact: Principal Investigator (Matteo Simonelli, MD)National Cancer Center Hospital, Chūōku, Japan
Contact: Principal Investigator (Noboru Yamamoto, MD)Hospital Universitari Vall d'Hebron, Barcelona, Spain
Contact: Principal Investigator (Enriqueta Felip Font, MD)Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
Contact: Principal Investigator (Margarita Majem Tarruella, MD)Hospital Beata María Ana, Madrid, Spain
Contact: Principal Investigator (Javier Cortes, MD)START Madrid / Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain
Contact: Principal Investigator (Ester Garcia Lorenzo, MD)Hospital Universitario 12 De Octubre, Madrid, Spain
Contact: Principal Investigator (Luis Paz-Ares Rodriguez, MD)START Madrid / Centro Integral Oncologico Clara Campal, Madrid, Spain
Contact: Principal Investigator (Maria Jose de Miguel Luken, MD)START Rioja, Piqueras, Spain
Contact: Study coordinator (Maria Jose de Miguel Luken)Contact: Principal Investigator (Maria Jose de Miguel Luken, MD)Hospital Universitario Virgen Macarena, Seville, Spain
Contact: Principal Investigator (David Vicente Baz, MD)
Study leads
Jimmy Zhao, MD, PhD
Study Director
SystImmune Inc.